This information is for educational and research purposes only. Always consult qualified healthcare professionals before beginning any peptide protocol.
Overview
Tesamorelin is a synthetic peptide and Growth Hormone-Releasing Hormone (GHRH) analog, FDA-approved for reducing visceral adipose tissue (VAT) in HIV-associated lipodystrophy. By stimulating the pituitary gland to increase natural growth hormone (GH) and IGF-1 production, it selectively targets dangerous belly fat while preserving muscle mass. This makes it particularly effective for body recomposition during cutting phases or for individuals with metabolic concerns related to visceral fat accumulation.
Key Benefits
- •Significantly reduces visceral abdominal fat (belly fat)
- •Improves insulin sensitivity and glucose metabolism
- •Enhances lipid profiles and cardiovascular health markers
- •Preserves lean muscle mass during caloric deficits
- •Supports improved body composition and metabolic health
- •Increases natural GH production without shutting down natural pathways
- •Ideal for recomposition goals (simultaneous fat loss and muscle retention)
Dosage Guidelines
Typical Dose
2 mg/day
Frequency
5 days per week (5 on/2 off protocol)
Duration
8-12 weeks
Administration
Subcutaneous injection before bed
Research Findings
- •Clinical studies report a 9.9% reduction in visceral adipose tissue over 6 months
- •Research shows improved triglyceride levels and cardiovascular risk markers
- •FDA-approved data demonstrates safe and effective visceral fat reduction
- •Studies indicate maintained muscle mass and strength during fat loss phases
- •Long-term trials show sustained benefits with continued use and proper cycling
Safety & Considerations
- •Generally well-tolerated with FDA approval for specific indications
- •May cause injection site reactions, water retention, or joint discomfort
- •Monitor glucose levels regularly, especially in pre-diabetic individuals
- •Elevated IGF-1 levels require periodic monitoring
- •Not recommended for individuals with active malignancies or history of cancer
- •May increase risk of glucose intolerance if doses are excessive
- •Consult healthcare provider for proper monitoring during extended use
Medical Disclaimer: The information provided is for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Individual results may vary. Always consult with qualified healthcare professionals before beginning any peptide protocol or making health-related decisions.